Sector Gamma ASA »

Intellia Therapeutics shares owned by Sector Gamma ASA

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Sector Gamma ASA from 13F filings

Historical chart of Sector Gamma ASA investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Sector Gamma ASA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Sector Gamma ASA

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.1M 185k 16.92

More positions owned by Sector Gamma ASA

Bristol Myers Squibb (BMY)
Merck & Co (MRK)
Medtronic SHS (MDT)
Pfizer (PFE)
Incyte Corporation (INCY)
Anthem (ELV)
BioMarin Pharmaceutical (BMRN)
Thermo Fisher Scientific (TMO)
CVS Caremark Corporation (CVS)
Iqvia Holdings (IQV)
Ionis Pharmaceuticals (IONS)
Becton, Dickinson and (BDX)
Abbott Laboratories (ABT)
Ge Healthcare Technologies I Common Stock (GEHC)
Zimmer Holdings (ZBH)

View all positions for Sector Gamma ASA

Top funds holding Intellia Therapeutics

ARK Investment Management
BlackRock
Vanguard Portfolio Management
State Street Corporation
D. E. Shaw & Co
Vanguard Capital Management
Two Sigma Investments
FMR
RA Capital Management
Regeneron Pharmaceuticals
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Dimensional Fund Advisors

View all funds holding Intellia Therapeutics